首页 > 市场调查报告书 > 医疗设备

体外诊断

大便潜血试验市场规模、份额及成长分析（依检测类型、最终用户及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902484

大便潜血试验市场规模、份额及成长分析（依检测类型、最终用户及地区划分）－2026-2033年产业预测

Fecal Occult Testing Market Size, Share, and Growth Analysis, By Test type (Immuno-FOB ELISA Test, Lateral Flow Immuno-FOB Test), By End-User (Hospitals and Clinics), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球大便潜血试验市场规模预计在 2024 年达到 2068.2 亿美元，从 2025 年的 2221.2 亿美元增长到 2033 年的 3932.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.4%。

全球大便潜血试验市场对于检测粪便中的隐血至关重要，而粪便隐血可能预示着多种疾病，包括大肠直肠癌、息肉和发炎性肠道疾病。大肠直肠癌发生率的上升、政府的宣传活动以及医疗和实验室技术的进步，都在推动这种筛检方法的需求。儘管存在公众认知度低和费用方面的顾虑等障碍，但面向消费者的直接检测服务的兴起和在线检测设备的普及带来了许多机会。该市场涵盖多种产品类型，例如癒创木脂大便潜血试验和免疫学大便潜血试验，并应用于包括医院和诊断检查室在内的各种临床场所。此外，该市场在全球主要地区也广泛分布。

推动全球大便潜血试验市场发展的因素

全球大便潜血试验市场受到大众对大肠直肠癌及其定期筛检重要性认知不断提高的显着影响。诸如健康政策和宣传宣传活动等措施鼓励个人和医疗专业人员将筛检放在首位。此外，政府主导的计画和已製定的指南，推广针对特定年龄层的定期大便潜血试验，也促进了此类诊断检测需求的增长。教育和系统性建议的结合，鼓励人们采取更积极主动的方式来预防和检测结直肠癌，从而推动大便潜血试验作为一项重要的健康措施在市场中占据一席之地。

限制全球大便潜血试验市场的因素

全球大便潜血试验市场面临假阳性和假阴性结果带来的重大挑战，这些结果会削弱诊断的可靠性，并加剧患者的焦虑和过度自信。假阳性结果可能导致不必要的额外检查或侵入性操作，而假阴性结果会延误诊断，进而延迟必要的治疗。因此，解决大便潜血试验在灵敏度和特异性方面的局限性，以确保人们对其诊断能力的持续信心至关重要。透过提高这些检测的准确性，市场可以更好地服务医疗服务提供者和患者，最终改善治疗效果和医疗品质。

全球大便潜血试验市场趋势

全球大便潜血试验市场正朝着就地检验（POC检测）方向发展，这主要受对更快检测结果和更高便利性的需求所驱动。这一趋势凸显了基层医疗机构、社区健康诊所和检测设施有限的偏远地区检测的可及性。开发易于使用、经济高效的照护现场大便潜血试验，为扩大筛检和诊断服务提供了重要机会，尤其是在资源匮乏的地区。随着医疗系统将早期发现和预防措施置于优先地位，市场蓄势待发，可望迎来成长，并推动创新，从而提高不同人群的检测可及性，改善患者预后。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Quidel Corporation（United States）
Wondfo（China）
Siemens Healthineers（Germany）
Eiken Chemical Co., Ltd.（Japan）
Biohit Oyj（Finland）
Becton, Dickinson and Company（BD）（United States）
Trinity Biotech（Ireland）
Meridian Bioscience（United States）
Beckman Coulter（United States）
Inova Diagnostics（United States）
Bio-Rad Laboratories（United States）
Abbott Laboratories（United States）
Roche Diagnostics（Switzerland）
Sysmex Corporation（Japan）
US Diagnostics（United States）
Sekisui Diagnostics（United States）
FUJIFILM Wako Pure Chemical Corporation（Japan）
Helena Laboratories（United States）
Exact Sciences Corp.（United States）

结论与建议

简介目录

Product Code: SQMIG35A2892

Global Fecal Occult Testing Market size was valued at USD 206.82 Billion in 2024 and is poised to grow from USD 222.12 Billion in 2025 to USD 393.22 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global fecal occult testing market is crucial for detecting hidden blood in stool samples, which is indicative of various medical conditions including colon cancer, polyps, and inflammatory bowel diseases. The demand for this screening method is increasing due to the rising incidence of colorectal cancer, government initiatives promoting awareness, and advancements in medical technology and testing techniques. Despite barriers such as low public awareness and cost concerns, opportunities abound through the rise of direct-to-consumer lab tests and the availability of testing devices online. The market encompasses different product types, such as guaiac FOB, immuno-FOB tests, and is utilized in various clinical settings including hospitals and diagnostic laboratories, with a broad geographical presence across key global regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fecal Occult Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fecal Occult Testing Market Segments Analysis

Global Fecal Occult Testing Market is segmented by Test Type, Application, End-use and region. Based on Test Type, the market is segmented into Guaiac FOB stool test, Immuno-FOB agglutination test, Lateral flow immuno-FOB test and Immuno-FOB ELISA test. Based on Application, the market is segmented into Colorectal Cancer, Gastrointestinal Bleeding, Anemia and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fecal Occult Testing Market

The Global Fecal Occult Testing market is significantly influenced by heightened public awareness surrounding colorectal cancer and the importance of regular screening measures. Efforts such as healthcare initiatives and awareness campaigns encourage both individuals and healthcare professionals to prioritize screening. Additionally, government-sponsored programs and established guidelines promoting routine fecal occult blood testing for specific age demographics contribute to the growing demand for these diagnostic tests. This combination of education and structured recommendations is fostering a more proactive approach to colorectal cancer prevention and detection, thereby boosting the market for fecal occult testing as an essential health measure.

Restraints in the Global Fecal Occult Testing Market

The global fecal occult testing market faces significant challenges related to the potential for false positive and false negative results, which can undermine diagnostic reliability and create patient concern or overconfidence. False positives may lead to unnecessary additional tests or invasive procedures, while false negatives can result in missed diagnoses, further delaying essential treatment. It is vital to address these limitations regarding the sensitivity and specificity of fecal occult blood tests to ensure continued trust in their diagnostic capabilities. By improving the accuracy of these tests, the market can better serve both healthcare providers and patients, ultimately enhancing outcomes and care quality.

Market Trends of the Global Fecal Occult Testing Market

The Global Fecal Occult Testing market is increasingly leaning towards point-of-care testing, driven by the demand for rapid results and enhanced convenience. This trend emphasizes accessibility in primary care settings, community health clinics, and remote areas with limited laboratory facilities. The development of user-friendly, cost-effective point-of-care fecal occult blood tests presents a significant opportunity to broaden screening and diagnostic services, particularly in resource-constrained environments. As healthcare systems prioritize early detection and preventive measures, the market is poised for growth, fostering innovations that facilitate access and improve patient outcomes across diverse populations.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Fecal Occult Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
Guaiac FOB stool test
Immuno-FOB agglutination test
Lateral flow immuno-FOB test
Immuno-FOB ELISA test

Global Fecal Occult Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Colorectal Cancer
Gastrointestinal Bleeding
Anemia
Others

Global Fecal Occult Testing Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic centers
Others

Global Fecal Occult Testing Market Size & CAGR (2026-2033)

North America (Test Type, Application, End-use)
- US
- Canada
Europe (Test Type, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Quidel Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wondfo (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eiken Chemical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biohit Oyj (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inova Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
US Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Wako Pure Chemical Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exact Sciences Corp. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments